样式: 排序: IF: - GO 导出 标记为已读
-
Enhancing the prediction of symptomatic radiation pneumonitis for locally advanced non-small-cell lung cancer by combining 3D deep learning-derived imaging features with dose–volume metrics: a two-center study Strahlenther Onkol. (IF 3.1) Pub Date : 2024-03-18 Yan Kong, Mingming Su, Yan Zhu, Xuan Li, Jinmeng Zhang, Wenchao Gu, Fei Yang, Jialiang Zhou, Jianjiao Ni, Xi Yang, Zhengfei Zhu, Jianfeng Huang
-
Spinal and cervical nodal metastases in a patient with glioblastoma Strahlenther Onkol. (IF 3.1) Pub Date : 2024-03-15 Silvio Heinig, Thomas Aigner, Heinz-Georg Bloß, Gerhard G. Grabenbauer
-
Radiotherapy in localized prostate cancer: a multicenter analysis evaluating tumor control and late toxicity after brachytherapy and external beam radiotherapy in 1293 patients Strahlenther Onkol. (IF 3.1) Pub Date : 2024-03-15 Matthias Moll, Elisabeth Nechvile, Christian Kirisits, Oxana Komina, Thomas Pajer, Bettina Kohl, Marcin Miszczyk, Joachim Widder, Tomas-Hendrik Knocke-Abulesz, Gregor Goldner
-
Assessment and validation of glottic motion using cone-beam CT and real-time cine MRI Strahlenther Onkol. (IF 3.1) Pub Date : 2024-03-15 Seok-Joo Chun, Jaeman Son, Seonghee Kang, Chang Heon Choi, Jung-in Kim, Young-Il Kim, Joo Ho Lee, Jin Ho Kim, Hong-Gyun Wu
-
DEGRO guideline for personalized radiotherapy of brain metastases and leptomeningeal carcinomatosis in patients with breast cancer Strahlenther Onkol. (IF 3.1) Pub Date : 2024-03-15 Kai J. Borm, Sophie T. Behzadi, Juliane Hörner-Rieber, David Krug, Rene Baumann, Stefanie Corradini, Marciana Nona Duma, Jürgen Dunst, Gerd Fastner, Petra Feyer, Rainer Fietkau, Wulf Haase, Wolfgang Harms, Thomas Hehr, Christiane Matuschek, Marc D. Piroth, Leonard Christopher Schmeel, Rainer Souchon, Vratislav Strnad, Wilfried Budach, Stephanie E. Combs
Purpose The aim of this review was to evaluate the existing evidence for radiotherapy for brain metastases in breast cancer patients and provide recommendations for the use of radiotherapy for brain metastases and leptomeningeal carcinomatosis. Materials and methods For the current review, a PubMed search was conducted including articles from 01/1985 to 05/2023. The search was performed using the following
-
Survival outcomes and treatment experience of 124 patients with primary central nervous system lymphoma Strahlenther Onkol. (IF 3.1) Pub Date : 2024-03-11 Ziqing Tang, Geting Wu, Fang Tan, Yang Long, Jidong Hong, Zhiping Lyu, Rui Wei
-
Vitexin enhances radiosensitivity of mouse subcutaneous xenograft glioma by affecting the miR-17-5p/miR-130b-3p/PTEN/HIF-1α pathway Strahlenther Onkol. (IF 3.1) Pub Date : 2024-03-07 Tao Xie, Yu-Hao Ding, Chun-Sheng Sang, Ze-Xi Lin, Jun Dong, Xi-An Fu
-
Visual hallucinations after resection of cerebral metastases: two patients with complex phantom images Strahlenther Onkol. (IF 3.1) Pub Date : 2024-03-07
Abstract Purpose Complex visual hallucinations are rarely seen in neurooncology. They are commonly observed alongside psychotic symptoms in schizophrenia or dementia, in Parkinson’s or Lewy-body disease, after opioid medications or anesthesia, and, in particular, they appear with visual impairments. Methods Here we report two normal-sighted and mentally healthy patients with unusual visual hallucinations
-
Longer time to testosterone recovery impacts favorably on outcomes for prostate cancer following androgen deprivation and radiotherapy Strahlenther Onkol. (IF 3.1) Pub Date : 2024-02-28 Susana Castro-Larefors, Maria Magdalena Marti-Laosa, Veronica Lopez-Honrubia, Irene Rey-Lopez, Beatriz Ruiz-Herrero, Yasmina Murria-Perez, Ignacio Andres, Isabel Elvira Jimenez-Garcia, Roberto Berenguer, Manuel Aguayo-Martos, Ricardo Sánchez-Prieto, Angeles Rovirosa, Esther Jimenez-Jimenez, Meritxell Arenas, Sebastià Sabater
-
Cost–benefit ratio of modern medical education using micro-costing: a model calculation using the example of an innovative breast brachytherapy workshop Strahlenther Onkol. (IF 3.1) Pub Date : 2024-02-28 Stefan Knippen, Marciana-Nona Duma, Michael Schwedas, Steffen Schrott, Sonja Drozdz, Irina Mäurer, Guido Hildebrandt, Matthias Mäurer
-
Transrectal ultrasound for intraoperative interstitial needle guidance in cervical cancer brachytherapy Strahlenther Onkol. (IF 3.1) Pub Date : 2024-02-26 J. Knoth, A. Sturdza, A. Zaharie, V. Dick, G. Kronreif, N. Nesvacil, J. Widder, C. Kirisits, M. P Schmid
-
Radiotherapy statements of the 18th St. Gallen International Breast Cancer Consensus Conference—a German expert perspective Strahlenther Onkol. (IF 3.1) Pub Date : 2024-02-23
Abstract Purpose To summarize the radiotherapy-relevant statements of the 18th St. Gallen Breast Cancer Consensus Conference and interpret the findings in light of German guideline recommendations. Methods Statements and voting results from the 18th St. Gallen International Breast Cancer Consensus Conference were collected and analyzed according to their relevance for the radiation oncology community
-
Evaluation of the safety and efficacy of high-dose rate brachytherapy for radiorecurrent prostate cancer: a systematic review and meta-analysis Strahlenther Onkol. (IF 3.1) Pub Date : 2024-02-22 Bin Shen, Jianjiang Liu, Dongping Wu, Jiayi Guo
-
Multidisciplinary survey on use of feeding tubes in head and neck cancer patients undergoing chemoradiotherapy in Germany—the SUFEETUBE project Strahlenther Onkol. (IF 3.1) Pub Date : 2024-02-21 Anastassia Löser, Alexander Fabian, Alexander Rühle, Alexander Thieme, Andrea Baehr, Lukas Käsmann, Inga Zwaan, Birte Kahle, Tamer Soror, Ameya Kunte, Niloufar Seyedi, Maxim Kebenko, Christoph Seidel, Friederike Dierks, Linda Krause, Karl-Ludwig Bruchhage, Dirk Rades
-
Intensity-modulated radiotherapy alone compared with intensity-modulated radiotherapy plus concurrent chemotherapy in intermediate-risk nasopharyngeal carcinoma Strahlenther Onkol. (IF 3.1) Pub Date : 2024-02-07 Shufang Liao, Bin Zhang, Yixin Su, Yufei Pan, Jian Zhang, Zhenkai Ye, Rongjun Zhang, Xiangyun Kong, Guanjie Qin, Yunyan Mo, Xiaolan Ruan, Jian Liu, Chunqiao Gan, Jinxuan Dai, Ruyun Zhang, Guanhong Luo, Xiaofei Liao, Wei Jiang
-
Dosimetric advantages for cardiac substructures in radiotherapy of esophageal cancer in deep-inspiration breath hold Strahlenther Onkol. (IF 3.1) Pub Date : 2024-02-05 Ahmed Allam Mohamed, Melina Nausikaa Douglas, Philipp Bruners, Michael J. Eble
-
Radiochemotherapy and interstitial brachytherapy for cervical cancer: clinical results and patient-reported outcome measures Strahlenther Onkol. (IF 3.1) Pub Date : 2024-01-31 Johanna Alfrink, Thomas Aigner, Hermann Zoche, Luitpold Distel, Gerhard G. Grabenbauer
-
Excellent long-term pain response and local control following postoperative radiotherapy in patients with multiple myeloma Strahlenther Onkol. (IF 3.1) Pub Date : 2024-01-30 Justus Kaufmann, Annika Ute Täubl, Eirini Nikolaidou, Alexander Rühle, Anne Hopprich, Daniel Wollschläger, Arnulf Mayer, Nils Henrik Nicolay, Heinz Schmidberger, Tilman Bostel
-
Ulcerating skin lesions from blastic plasmacytoid dendritic cell neoplasm responding to low-dose radiotherapy—a case report and literature review Strahlenther Onkol. (IF 3.1) Pub Date : 2024-01-29 Elgin Hoffmann, Simon Böke, Chiara De-Colle, Claudia Lengerke, Karim-Maximilian Niyazi, Cihan Gani
-
Prostate cancer and elective nodal radiation therapy for cN0 and pN0—a never ending story? Strahlenther Onkol. (IF 3.1) Pub Date : 2024-01-25 S. A. Koerber, S. Höcht, D. Aebersold, C. Albrecht, D. Boehmer, U. Ganswindt, N.-S. Schmidt-Hegemann, T. Hölscher, A.-C. Mueller, P. Niehoff, J. C. Peeken, M. Pinkawa, B. Polat, S. K. B. Spohn, F. Wolf, C. Zamboglou, D. Zips, T. Wiegel
For prostate cancer, the role of elective nodal irradiation (ENI) for cN0 or pN0 patients has been under discussion for years. Considering the recent publications of randomized controlled trials, the prostate cancer expert panel of the German Society of Radiation Oncology (DEGRO) aimed to discuss and summarize the current literature. Modern trials have been recently published for both treatment-naïve
-
Treatment-related pneumonitis after thoracic radiotherapy/chemoradiotherapy combined with anti-PD-1 monoclonal antibodies in advanced esophageal squamous cell carcinoma Strahlenther Onkol. (IF 3.1) Pub Date : 2024-01-24 Xiaoyan Lv, Yajing Wu, Qihui Li, Chen Zheng, Qiang Lin, Qingsong Pang, Min Zhao, Jiandong Zhang, Jun Wang
-
The role of artificial intelligence in informed patient consent for radiotherapy treatments—a case report Strahlenther Onkol. (IF 3.1) Pub Date : 2024-01-05
Abstract Recent advancements in large language models (LMM; e.g., ChatGPT (OpenAI, San Francisco, California, USA)) have seen widespread use in various fields, including healthcare. This case study reports on the first use of LMM in a pretreatment discussion and in obtaining informed consent for a radiation oncology treatment. Further, the reproducibility of the replies by ChatGPT 3.5 was analyzed
-
Stereotactic body radiotherapy (SIB-VMAT technique) to dominant intraprostatic lesion (DIL) for localized prostate cancer: a dose-escalation trial (DESTROY-4). Strahlenther Onkol. (IF 3.1) Pub Date : 2024-01-05 Francesco Deodato, Milena Ferro, Paolo Bonome, Donato Pezzulla, Carmela Romano, Milly Buwenge, Savino Cilla, Alessio Giuseppe Morganti, Gabriella Macchia
-
Six-year outcomes of robot-assisted radical prostatectomy versus volumetric modulated arc therapy for localized prostate cancer: A propensity score-matched analysis Strahlenther Onkol. (IF 3.1) Pub Date : 2024-01-05 Michio Noda, Satoru Taguchi, Kenshiro Shiraishi, Tetsuya Fujimura, Akihiro Naito, Taketo Kawai, Jun Kamei, Yoshiyuki Akiyama, Yuta Yamada, Yusuke Sato, Daisuke Yamada, Tohru Nakagawa, Hideomi Yamashita, Keiichi Nakagawa, Osamu Abe, Hiroshi Fukuhara, Haruki Kume
-
Biological treatment evaluation in thermoradiotherapy: application in cervical cancer patients Strahlenther Onkol. (IF 3.1) Pub Date : 2024-01-04 H. P. Kok, T. D. Herrera, J. Crezee
-
Quality requirements for MRI simulation in cranial stereotactic radiotherapy: a guideline from the German Taskforce “Imaging in Stereotactic Radiotherapy” Strahlenther Onkol. (IF 3.1) Pub Date : 2024-01-02
Abstract Accurate Magnetic Resonance Imaging (MRI) simulation is fundamental for high-precision stereotactic radiosurgery and fractionated stereotactic radiotherapy, collectively referred to as stereotactic radiotherapy (SRT), to deliver doses of high biological effectiveness to well-defined cranial targets. Multiple MRI hardware related factors as well as scanner configuration and sequence protocol
-
Post-mastectomy reirradiation for ipsilateral T3N0M0 breast tumor relapse: a population-based study Strahlenther Onkol. (IF 3.1) Pub Date : 2024-01-02
Abstract Introduction Post-mastectomy radiotherapy is commonly recommended for T3N0M0 breast cancer, particularly in the presence of adverse prognostic factors. However, for T3N0M0 ipsilateral recurrences following breast-conserving surgery and adjuvant radiotherapy, the situation is distinct. Recurrence alone signifies a negative prognostic factor. Moreover, tumor relapses within previously irradiated
-
Stereotactic body radiotherapy (SBRT) re-irradiation for local failures following radical prostatectomy and post-operative radiotherapy Strahlenther Onkol. (IF 3.1) Pub Date : 2023-12-29 Wojciech Majewski, Marcin Miszczyk, Donata Graupner, Bartłomiej Goc, Gregor Goldner, Aleksandra Napieralska
-
Is a total dose of 54 Gy with radiochemotherapy sufficient for treatment of intermediate-risk volumes in nasopharyngeal cancer? Strahlenther Onkol. (IF 3.1) Pub Date : 2023-12-28 Meltem Dağdelen, Tuba Kurt Çatal, Songül Çavdar Karaçam, Emine Sedef Akovalı, Sevda Kanat, Halil Cumhur Yıldırım, Ömer Erol Uzel
-
Can interventional radiotherapy (brachytherapy) be an alternative to surgery in early-stage oral cavity cancer? A systematic review Strahlenther Onkol. (IF 3.1) Pub Date : 2023-12-18 Lorena Draghini, Valentina Lancellotta, Bruno Fionda, Martina De Angeli, Patrizia Cornacchione, Mariangela Massaccesi, Fabio Trippa, Gyoergy Kovács, Alessio Giuseppe Morganti, Francesco Bussu, Roberto Iezzi, Luca Tagliaferri
-
Stereotactic body radiotherapy with volumetric intensity-modulated arc therapy and flattening filter-free beams: dosimetric considerations Strahlenther Onkol. (IF 3.1) Pub Date : 2023-12-13 Mark Christoph Brekner, Detlef Imhoff, Claus Rödel, Natalie Filmann, Jörg Licher, Ulla Ramm, Janett Köhn
-
Stereotactic radiotherapy in the management of oligometastatic and recurrent head and neck cancer: a single-center experience Strahlenther Onkol. (IF 3.1) Pub Date : 2023-12-08 Ahmed Allam Mohamed, Miguel Goncalves, Biney Pal Singh, Mareike Tometten, Ashkan Rashad, Frank Hölzle, Stephan Hackenberg, Michael Eble
-
Survey in radiation oncology departments in Germany, Austria, and Switzerland: state of digitalization by 2023 Strahlenther Onkol. (IF 3.1) Pub Date : 2023-12-05 Stefan Janssen, Rami A. El Shafie, Maximilian Grohmann, Stefan Knippen, Paul M. Putora, Marcus Beck, Andrea Baehr, Patrick Clemens, Sarah Stefanowicz, Dirk Rades, Jan-Niklas Becker, Fabian B. Fahlbusch
-
Clinical outcomes and failure patterns after postoperative radiotherapy for oral cavity squamous cell carcinoma Strahlenther Onkol. (IF 3.1) Pub Date : 2023-11-24 Saori Tatsuno, Hiroshi Doi, Masahiro Inada, Takuya Uehara, Yutaro Wada, Kazuki Ishikawa, Kaoru Tanaka, Mutsukazu Kitano, Yasumasa Nishimura
-
Reirradiation with radiosurgery or stereotactic fractionated radiotherapy in association with regorafenib in recurrent glioblastoma Strahlenther Onkol. (IF 3.1) Pub Date : 2023-11-21 Fabiana Gregucci, Fiorella Cristina Di Guglielmo, Alessia Surgo, Roberta Carbonara, Letizia Laera, Maria Paola Ciliberti, Maria Annunziata Gentile, Roberto Calbi, Morena Caliandro, Nicola Sasso, Valerio Davi’, Ilaria Bonaparte, Vincenzo Fanelli, David Giraldi, Romina Tortora, Valeria Internò, Francesco Giuliani, Giammarco Surico, Francesco Signorelli, Giuseppe Lombardi, Alba Fiorentino
-
Future prospects in radiation oncology from the perspective of innovative radiation biology. Strahlenther Onkol. (IF 3.1) Pub Date : 2023-11-24 Franz Rödel,Udo Gaipl
-
Safety and efficacy of helical tomotherapy following lung-sparing surgery in locally advanced malignant pleural mesothelioma Strahlenther Onkol. (IF 3.1) Pub Date : 2023-11-22 Julian P. Layer, Pascal Fischer, Cas S. Dejonckheere, Gustavo R. Sarria, Rebekka Mispelbaum, Sandra Tessa Hattenhauer, Shari Wiegreffe, Andrea R. Glasmacher, Katharina Layer, Youness Nour, Lara Caglayan, Franziska Grau, Thomas Müdder, Mümtaz Köksal, Davide Scafa, Frank A. Giordano, Alberto Lopez-Pastorini, Erich Stoelben, Leonard Christopher Schmeel, Christina Leitzen
-
[Improved swallowing function after definitive radiochemotherapy for oropharyngeal and hypopharyngeal cancer by sparing of the pharyngeal constrictor muscles]. Strahlenther Onkol. (IF 3.1) Pub Date : 2023-11-20 Alexander M Ziebolz
-
[Vorasidenib for low-grade gliomas-new treatment option with unanswered questions regarding long-term outcomes]. Strahlenther Onkol. (IF 3.1) Pub Date : 2023-11-20 Clemens Seidel,Nils H Nicolay
-
Satisfaction with radiotherapy care among cancer patients treated in Germany—secondary analysis of a large multicenter study Strahlenther Onkol. (IF 3.1) Pub Date : 2023-11-17 Alexander Fabian, Alexander Rühle, Justus Domschikowski, Maike Trommer, Simone Wegen, Jan-Niklas Becker, Georg Wurschi, Simon Boeke, Mathias Sonnhoff, Christoph A. Fink, Lukas Käsmann, Melanie Schneider, Elodie Bockelmann, Martin Treppner, Anja Mehnert-Theuerkauf, Nils H. Nicolay, David Krug
-
First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis Strahlenther Onkol. (IF 3.1) Pub Date : 2023-11-17 Kerstin Hofstetter, Julian Taugner, Lukas Käsmann, Sina Mansoorian, Benedikt Flörsch, Chukwuka Eze, Amanda Tufman, Niels Reinmuth, Thomas Duell, Claus Belka, Farkhad Manapov
-
Comparison of patient setup accuracy for optical surface-guided and X-ray-guided imaging with respect to the impact on intracranial stereotactic radiotherapy Strahlenther Onkol. (IF 3.1) Pub Date : 2023-11-16 Michael Schöpe, Jacob Sahlmann, Stefan Jaschik, Anne Findeisen, Gunther Klautke
-
Osthole inhibits GSK-3β/AMPK/mTOR pathway-controlled glycolysis and increases radiosensitivity of subcutaneous transplanted hepatocellular carcinoma in nude mice Strahlenther Onkol. (IF 3.1) Pub Date : 2023-11-14 Hui Huang, Jie Xue, Mei-Lin Xie, Tao Xie
-
The impact of submandibular glands protection on xerostomia as monitored by diffusion-weighted imaging in nasopharyngeal carcinoma patients Strahlenther Onkol. (IF 3.1) Pub Date : 2023-11-13 Dawei Zhao, Wenjun Fan, Huayong Jiang, Lingling Meng, Boning Cai, Xinxin Zhang, Wei Yu, Lujun Zhao, Lin Ma
-
[Is radiotherapy for diffuse large B-cell lymphoma obsolete? : A radio-oncological view on the UNFOLDER study]. Strahlenther Onkol. (IF 3.1) Pub Date : 2023-11-14 Michael Oertel,Hans Theodor Eich
-
Extranodal nasal-type NK/T lymphoma treated with chemotherapy and radiotherapy: case series from a European tertiary referral center and review of the literature Strahlenther Onkol. (IF 3.1) Pub Date : 2023-11-09 Judith Porte, Christophe Hennequin, Daphné Krizch, Laetitia Vercellino, Sophie Guillerm, Catherine Thieblemont, Laurent Quéro
-
Oncologic treatment support via a dedicated mobile app: a prospective feasibility evaluation (OPTIMISE-1) Strahlenther Onkol. (IF 3.1) Pub Date : 2023-11-10 Fabian A. Schunn, Rami A. El Shafie, Dorothea Kronsteiner, Lukas D. Sauer, Andreas Kudak, Nina Bougatf, Dieter Oetzel, Anna Krämer, Sebastian Regnery, Timo Machmer, Jürgen Debus, Nils Henrik Nicolay
-
Radiation therapy of breast cancer in the Nahe Breast Center: first results of an analysis in the context of health services research Strahlenther Onkol. (IF 3.1) Pub Date : 2023-11-10 Ralph Mücke, Gabor Heim, Robert Gosenheimer, Volker Schmitz, Christoph Schulz, Per Knoeß, Khashayar Fakhrian, Christina Harvey, Christiane Mücke, Gabriele Lochhas, Ute Metzmann, Matthias Bussmann, Markus Paschold
-
Successful implementation of online educational lectures of the German Society for Radiation Oncology (DEGRO) Strahlenther Onkol. (IF 3.1) Pub Date : 2023-10-27 Marcel Büttner, Philip Melton, Rainer Fietkau, Cordula Petersen, Mechthild Krause, Kerstin Borgmann, Ulrich Wolf, Maximilian Niyazi, Hans Christiansen, Ulrike Höller, Daniela Schmitt, Lukas Käsmann, Philipp Linde, Daniel F. Fleischmann, Sonia Ziegler, Angelique Bresch, Matthias Mäurer
-
High-LET charged particles: radiobiology and application for new approaches in radiotherapy Strahlenther Onkol. (IF 3.1) Pub Date : 2023-10-23 Alexander Helm, Claudia Fournier
-
Institutional experience report on the target contouring workflow in the radiotherapy department for stereotactic arrhythmia radioablation delivered on conventional linear accelerators Strahlenther Onkol. (IF 3.1) Pub Date : 2023-10-23 Mihaela Rosu-Bubulac, Cory R. Trankle, Pranav Mankad, John D. Grizzard, Kenneth A. Ellenbogen, Jennifer H. Jordan, Elisabeth Weiss
-
[The combination of stereotactic radiotherapy with checkpoint inhibitors: results of the CHEERS phase II trial]. Strahlenther Onkol. (IF 3.1) Pub Date : 2023-10-19 Tobias Mohr
-
[BRCA-like breast cancer patients benefit from cisplatin plus veliparib-results from the S1416 phase II study]. Strahlenther Onkol. (IF 3.1) Pub Date : 2023-10-12 Katharina Hintelmann,Kerstin Borgmann
-
ArthroRad trial: randomized multicenter single-blinded trial on the effect of low-dose radiotherapy for painful osteoarthritis—final results after 12-month follow-up Strahlenther Onkol. (IF 3.1) Pub Date : 2023-10-10 Marcus Niewald, Sobhan Moumeniahangar, Lara N. Müller, Matthias G. Hautmann, Yvonne Dzierma, Jochen Fleckenstein, Stefan Gräber, Christian Rübe, Markus Hecht, Patrick Melchior
-
[Neoadjuvant chemotherapy in operable colon cancer: is this a potential new standard?] Strahlenther Onkol. (IF 3.1) Pub Date : 2023-10-10 Georg W Wurschi
-
Radiotherapy for benign diseases in Turkey: a patterns of care survey of the Turkish Society for Radiation Oncology (TROD 05-002) Strahlenther Onkol. (IF 3.1) Pub Date : 2023-10-05 Halil Cumhur Yıldırım, Fazilet Öner Dinçbaş, Volkan Demircan, Murat Beyzadeoğlu, Ertuğrul Tekçe, Gözde Yazıcı, Menekşe Turna, Oğuz Çetinayak, Kudret Ensarioğlu Baktır, Mustafa Akın, Emine Canyılmaz, Ayse Altınok, Ela Delikgöz Soykut, Müge Akmansu, Fuzuli Tuğrul, Seda Ünverdi, Berrin Benli Yavuz, Serra Kamer, Mürsel Düzova, Sumerya Duru Birgi, Emine Elif Özkan, Berrin Yalçın, Merve Şahin, Durmuş Etiz
-
Stereoscopic X-ray image and thermo-optical surface guidance for breast cancer radiotherapy in deep inspiration breath-hold Strahlenther Onkol. (IF 3.1) Pub Date : 2023-10-05 Martin Buschmann, Daniela Kauer-Dorner, Stefan Konrad, Dietmar Georg, Joachim Widder, Barbara Knäusl
-
Intraoperative radiotherapy (IORT) of early breast cancer with low-energy x-rays in breast-conserving surgery Strahlenther Onkol. (IF 3.1) Pub Date : 2023-10-04 Anja Grimm, Eva Wollmann, Elena Sperk, Christel Weiß, Marc Sütterlin, Sebastian Berlit, Benjamin Tuschy
-
[Organ-sparing treatment of node-positive bladder cancer]. Strahlenther Onkol. (IF 3.1) Pub Date : 2023-09-29 Małgorzata Toroń,Antoni Wołoszyn
-
Decrease of radiation-induced skin reactions in breast cancer patients by preventive application of film dressings—a systematic review Strahlenther Onkol. (IF 3.1) Pub Date : 2023-09-27 Judith Kraemer, Felix Momm